What can we learn from pathophysiology and therapeutic targetable pathways from all genetic causes and associations in PH?
2024

Understanding Genetic Causes of Pulmonary Hypertension

publication

Author Information

Author(s): Angela Balistrieri, Eckart De Bie, Mark Toshner

Primary Institution: VPD Heart and Lung Research Institute, University of Cambridge, United Kingdom

Hypothesis

What can we learn from pathophysiology and therapeutic targetable pathways from all genetic causes and associations in pulmonary hypertension?

Conclusion

The study highlights the importance of understanding the genetics of pulmonary hypertension to identify potential therapeutic targets.

Supporting Evidence

  • Pulmonary hypertension affects up to 1% of the world's population.
  • Most forms of pulmonary hypertension are currently incurable and associated with significant mortality.
  • Genetic mutations in the BMPR2 gene are a major cause of heritable pulmonary arterial hypertension.

Takeaway

Pulmonary hypertension is a serious condition caused by various genetic factors, and learning about these can help us find better treatments.

Digital Object Identifier (DOI)

10.1016/j.ijcchd.2024.100523

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication